DOI QR코드

DOI QR Code

Formulation of mBHT (Modified BoyangHwanoTang) Orally Disintegrating Tablet for Therapeutics of Stroke

뇌졸중 예방 및 치료를 위한 가미보양환오탕 구강붕해정 제형 연구

  • Published : 2009.12.20

Abstract

According to the statistical data, stroke is about 13.9% of leading causes of death. Some herbal medicines including Paeonia lactiflora, Angelica gigas nakai and Prunus persica, etc., had been reported to be effective in preventing stroke and mBHT (Modified BoyangHwanoTang) was an advanced prescription used in Korean clinics. Orally disintegrating tablets (ODT) is useful for patients suffering from dysphagia, motion sickness, repeated emesis and mental disorders. Further, drugs exhibiting satisfactory absorption through the mucosa intended for immediate pharmacological action could be advantageously formulated in ODT. The aim of this study was to develop the most efficient ODT formulation of mBHT. Corresponding herbal medicines comprising mBHT were extracted with water for 3 hr at 95~$100{^{\circ}C}$ and then dried. mBHT extract was obtained with about 30% of yield. Subsequently, some pharmaceutical excipients such as spray-dried lactose, crospovidone, glyceryl behenate and/or cogrinded-treated arabia gum were used to achieve an immediate disintegration of mBHT ODT in oral cavity. The requirements of ODT with mechanical strength sufficient to stand the rigors of handling and capability of disintegrating within a few seconds in contact with saliva are indispensable. mBHT ODT prepared by the wet granulation method showed a disintegration time of below 30 sec.

Keywords

References

  1. 박선영, 구영덕, 김원기. BA407. 2005 미래유망 사업아이템 이슈분석. 뇌질환치료제II: 뇌졸중치료제 개발동향 및 전략. 한국과학기술정보연구원 보고서. 1-7 (2005).
  2. Ben Collins and Christine Hollidge, “Antithrombotiv Drug Market,” Nature Reviews Drug Discovery, 2(1), 11-12 (2003). https://doi.org/10.1038/nrd966
  3. 김창민. 가미보양환오탕 완제의 허혈성 뇌졸중 동물에서 뇌경색 치료효과 및 뇌신경보호기전 연구. 동국대학교 대학원 (2009).
  4. L. San, M. Casillas, A. Ciudad and I. Gilaberte, Olanzapine orally disintegrating tablet: a review of efficacy and compliance, CNS Neurosci. Ther., 14, 203-214 (2008). https://doi.org/10.1111/j.1755-5949.2008.00053.x
  5. T.J Gan, R. Franiak and J. Reeves, Ondansetron orally disintegrating tablet versus placebo for the prevention of post discharge nausea and vomiting after ambulatory surgery, Anesth. Analg., 94, 1199-1200 (2002). https://doi.org/10.1097/00000539-200205000-00027
  6. P. Chue, R. Welch and C. Binder, Acceptability and disintegration rates of orally disintegrating risperidone tablets in patients with schizophrenia or schizo-affective disorder, Can. J. Psychiatry, 49, 701-703 (2004). https://doi.org/10.1177/070674370404901009
  7. Green, W. Don, Perry's chemical engineer's handbook, McGraw-Hill Professional, pp. 1-2640 (2007).
  8. R.L. Carr, Evaluation of flow properties of solids. Chem. Eng., 72, 163-168 (1965).